MELBOURNE, AUSTRALIA--(Marketwire - December 11, 2007) - Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders, today announced that Rudolph E. Tanzi, Ph.D., Co-Founding Scientist of Prana Biotechnology, is scheduled to present "The Amyloid Hypotheses of Alzheimer's Disease," an expert panel on Alzheimer's Disease hosted by Credit Suisse Conference on December 14, 2007 at 10:00 a.m.
